Articles tagged "Adverse effects"

2019 American Transplant Congress
Pneumocystis Prophylaxis in Solid Organ Transplant Recipients at Two Large Transplant Centers from 2015-2016: Why Not Trimethoprim-Sulfamethoxazole?
J. M. Lum¹, V. Athans², I. Echenique³, C. E. Koval¹
¹Infectious Diseases, Cleveland Clinic Floundation, Cleveland, OH, ²Infectious Diseases, University of Pennsylvania, Philadelphia, PA, ³Infectious Diseases, Cleveland Clinic Florida, Weston, FL
*Purpose: Trimethoprim-sulfamethoxazole (T/S) is the drug of choice for Pneumocystis jirovecii pneumonia (PJP) prophylaxis (ppx) after solid organ transplant (SOT). Perceived side effects may lead…
2019 American Transplant Congress
Renal Function between Tenofovir and Entecavir in Post-Liver Transplanted Hepatitis B Patients
S. Kim, J. Kim, S. Lee, J. Rhu, Y. Chung, S. Kim, J. Joh, S. Lee, G. Choi, J. Park, S. Lee, K. Lee
Transplantation, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: Tenofovir, Nucleotide analogue polymerase inhibitor is already accepted as effective and tolerable drug for treatment of hepatitis B virus (HBV) as much as entecavir.…
2019 American Transplant Congress
Cholecystitis in High-Acuity Patients Undergoing Liver Transplantation: A Five-Year Analysis of Incidence, Causes and Impact
D. S. Graham, T. Ito, M. M. Lu, J. DiNorcia, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas
Dumont-UCLA Liver Transplant Center, Department of Surgery, UCLA School of Medicine, Los Angeles, CA
*Purpose: While the incidence of gallbladder pathology is well described in the general population, there is almost no data on cholecystitis in liver transplant candidates…
2019 American Transplant Congress
Safety and Efficacy of Peri-Operative Sublingual Tacrolimus in Pancreas Transplant as Compared to Oral Tacrolimus
N. Patel, C. Perez, D. Taber, V. Kalbavi, V. Rohan
MUSC, Charleston, SC
*Purpose: Early post-transplant, use of oral or enteral medications in pancreas transplant (PTX) is difficult due to NG tubes put to suction. The use of…
2019 American Transplant Congress
Metabolomic Study Of Sarcopenia In Patients Prior To Liver Transplantation
S. Ries,¹, N. J. Skill¹, E. Campbell¹, R. Daniel², C. A. Kubal¹, M. S. Richard¹, M. A. Maluccio¹
¹Surgery, Indiana University, Indianapolis, IN, ²University of Washington, Seattle, WA
*Purpose: Sarcopenia is defined as the loss of muscle mass, typically associated with aging, but frequently appearing in liver disease patients. In particular, sarcopenia present…
2019 American Transplant Congress
Blockade of IL-1β and TNF-α Does Not Significantly Pose Risk or Affect Outcomes in Patients Infused with Microbial-Positive Autologous Islet Preparations
K. Kumano¹, C. Darden², S. Vasu¹, M. Lawrence¹, B. Naziruddin³, A. Gupta³, E. Beecherl³, N. Onaca³
¹Baylor Scott and White Research Institute, Dallas, TX, ²Baylor University, Waco, TX, ³Baylor Simmons Transplant Institute, Dallas, TX
*Purpose: We recently demonstrated that the combined use of anakinra (IL-1β blocker) and etanercept (TNF-α blocker) improved outcomes of islet autotransplantation after total pancreatectomy (TPIAT).…
2019 American Transplant Congress
Determinants of Allograft Injury during Procurement in Deceased Donors
E. Taber-Hight¹, R. Cauwels², E. Eidbo², A. S. Paramesh³, R. Squires⁴, T. Taber¹
¹Nephrology, Indiana University, Indianapolis, IN, ²AOPO, Vienna, VA, ³Louisiana Organ Procurement Agency, New Orleans, LA, ⁴University of Oklahoma, Oklahoma City, OK
*Purpose: With the ever enlarging list of potential recipients on the transplant list, the need for deceased donor organs has become critical. Avoiding injury to…
2019 American Transplant Congress
Correlation between Self-Reported Medication Adherence and Side Effects in Transplant Recipients
T. Harrison¹, K. Foster¹, N. Patel¹, H. Meadows¹, C. Perez¹, H. Corbo¹, J. Fleming¹, N. Pilch¹, D. DuBay², J. McGillicuddy², S. Nadig², V. Rohan², D. Taber¹
¹Pharmacy Services, Medical University of South Carolina, Charleston, SC, ²Transplant Surgery, Medical University of South Carolina, Charleston, SC
*Purpose: Medication non-adherence (MNA) is a major risk factor for acute rejection and graft loss amongst all organ groups. It is unclear how medication side…
2019 American Transplant Congress
Hepatitis Flare in Hepatitis B Core Antibody Positive Kidney Recipients Treated with Rituximab
M. Raja¹, Y. Natori¹, C. Donato¹, D. De Lima¹, J. Rivollo², A. Centeno², Y. Ebisu¹, L. Abbo¹, J. Simkins¹, S. Anjan¹, J. Camargo¹, M. I. Morris¹
¹Internal Medicine, University of Miami Miller School of Medicine, Miami, FL, ²Jackson Memorial Hospital, Miami, FL
*Purpose: Patients with Hepatitis B Core Antibody (anti-HBc Ab) positive are known to be at risk for Hepatitis B virus (HBV) reactivation during periods of…
2019 American Transplant Congress
Parental Anxiety and Depression Rates across Pediatric Solid Organ Transplant Populations
A. M. Lofton¹, A. Wille¹, E. A. Steinberg², C. Buchanan²
¹Psychiatry, Children's Hospital Colorado, Aurora, CO, ²Psychiatry, University of Colorado SOM, Children's Hospital Colorado, Aurora, CO
*Purpose: This study’s purpose is to examine parental self-report of depression and anxiety symptoms during the pre-transplant evaluation process for solid organ transplant pediatric candidates…